BioXcel Therapeutics Inc
(NAS:BTAI)
$
0.659
-0.0482 (-6.82%)
Market Cap: 26.85 Mil
Enterprise Value: 75.81 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 21/100 - Q2 2024 BioXcel Therapeutics Inc Earnings Call TranscriptAug 06, 2024$0.96 (+4.34%)Earnings
- Q4 2023 BioXcel Therapeutics Inc Earnings Call TranscriptMar 12, 2024$2.77 (-4.48%)Earnings
- BioXcel Therapeutics Inc To Host Neuroscience R&D Day TranscriptDec 12, 2023
- Q3 2023 BioXcel Therapeutics Inc Earnings Call TranscriptNov 14, 2023$4.22 (-23.41%)Earnings
- BioXcel Therapeutics Inc To Discuss The Data Results From The Phase 2 Trial of BXCL701 Call TranscriptOct 10, 2023
- Q2 2023 BioXcel Therapeutics Inc Earnings Call TranscriptAug 14, 2023$4.33 (-41.49%)Earnings
- BioXcel Therapeutics Inc To Discuss TRANQUILITY II Top-Line Results Call TranscriptJun 29, 2023
- BioXcel Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- BioXcel Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- BioXcel Therapeutics Inc To Discuss The Pivotal Phase 3 SERENITY III Part 1 Trial Results Call TranscriptMay 25, 2023
- BioXcel Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 BioXcel Therapeutics Inc Earnings Call TranscriptMay 08, 2023$26.33 (+13.64%)Earnings
- Q4 2022 BioXcel Therapeutics Inc Earnings Call TranscriptMar 09, 2023$24.56 (-13.40%)Earnings
- BioXcel Therapeutics Inc To Host BXCL701 Key Opinion Leader Day TranscriptFeb 21, 2023
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- BioXcel Therapeutics Inc at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Q3 2022 BioXcel Therapeutics Inc Earnings Call TranscriptNov 10, 2022$14.75 (+29.27%)Earnings
- BioXcel Therapeutics Inc Commercial Day TranscriptOct 18, 2022
- Q2 2022 BioXcel Therapeutics Inc Earnings Call TranscriptAug 09, 2022$15.36 (-7.58%)Earnings
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 23, 2022
- BioXcel Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 BioXcel Therapeutics Inc Earnings Call TranscriptMay 09, 2022$11.36 (-9.55%)Earnings
- BioXcel Therapeutics Inc To Discuss The FDA Approval Of IGALMI Call TranscriptApr 06, 2022
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2022
- Q4 2021 BioXcel Therapeutics Inc Earnings Call TranscriptMar 10, 2022$18.11 (-4.13%)Earnings
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2022
- Q3 2021 BioXcel Therapeutics Inc Earnings Call TranscriptNov 10, 2021$34.28 (+1.21%)Earnings
- BioXcel Therapeutics Inc To Host Virtual R&D Day TranscriptSep 23, 2021
- Q2 2021 BioXcel Therapeutics Inc Earnings Call TranscriptAug 10, 2021$24.93 (-0.24%)Earnings
- BioXcel Therapeutics Inc Commercial Day TranscriptJun 25, 2021
- BioXcel Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 14, 2021
- BioXcel Therapeutics Inc Annual Shareholders Meeting TranscriptJun 11, 2021
- BioXcel Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- BioXcel Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- BioXcel Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 BioXcel Therapeutics Inc Earnings Call TranscriptMay 10, 2021$30.4 (-0.39%)Earnings
- Q4 2020 BioXcel Therapeutics Inc Earnings Call TranscriptMar 11, 2021$47.2 (+4.31%)Earnings
- BioXcel Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- BioXcel Therapeutics, Inc. - Special Call TranscriptJan 05, 2021
- Q3 2020 BioXcel Therapeutics Inc Earnings Call TranscriptNov 12, 2020$55.06 (-2.69%)Earnings
- Q2 2020 BioXcel Therapeutics Inc Earnings Call TranscriptAug 14, 2020$37.52 (-16.08%)Earnings
- BioXcel Therapeutics, Inc. - Special Call TranscriptJul 20, 2020
- BioXcel Therapeutics Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 24, 2020
- BioXcel Therapeutics Inc Annual Shareholders Meeting TranscriptMay 20, 2020
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference (Virtual) TranscriptMay 18, 2020
- BioXcel Therapeutics Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 14, 2020
- Q1 2020 BioXcel Therapeutics Inc Earnings Call TranscriptMay 12, 2020$40.68 (-5.42%)Earnings
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 10, 2020
- Q4 2019 BioXcel Therapeutics Inc Earnings Call TranscriptMar 09, 2020$29.14 (-11.86%)Earnings
- Q3 2019 BioXcel Therapeutics Inc Earnings Call TranscriptNov 14, 2019$4.36 (-4.80%)Earnings
- Q2 2019 BioXcel Therapeutics Inc Earnings Call TranscriptAug 06, 2019$8.85 (-3.17%)Earnings
- BioXcel Therapeutics, Inc. - Special Call TranscriptJul 22, 2019
- BioXcel Therapeutics Inc Corporate Analyst Meeting TranscriptMay 22, 2019
- BioXcel Therapeutics Inc at UBS Global Healthcare Conference TranscriptMay 20, 2019
- BioXcel Therapeutics, Inc. To Discuss Achieved Targeted Exposures of BXCL501 Conference Call TranscriptMay 20, 2019
- Q1 2019 BioXcel Therapeutics Inc Earnings Call TranscriptMay 07, 2019$10.83 (+3.64%)Earnings
- BioXcel Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 BioXcel Therapeutics Inc Earnings Call TranscriptMar 07, 2019$7.91 (-4.93%)Earnings
BioXcel Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 09, 2021 / 03:40PM GMT
Release Date Price:
$38.83
(+2.67%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay. Good afternoon, everyone, and welcome to the 4:40 p.m. session here on day 2 at the Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover U.S. and European biopharma names here at the firm. It's my great pleasure to be hosting BioXcel Therapeutics in a fireside chat. And with that, joining from the company are CEO, Vimal Mehta; and Chief Commercialization Officer; William Kane. Gentlemen, it's good to see you both, and welcome.
Vimal D. Mehta
BioXcel Therapeutics, Inc. - Founder, CEO, President, & Director
Thank you, Graig.
William P. Kane
BioXcel Therapeutics, Inc. - Executive VP & Chief Commercial Officer
Thank you, Graig.
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Okay, very well. Well, my sense is there's probably a number of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)